2/22/24 16:32 | 2/21/24 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pfreundschuh Peter P. | MA | O | CFO | S | -28 | 7.46 | 0 | -4 | -2 | 176 | D | | | | | | | | | | | | | | |
10/5/23 16:41 | 10/3/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pfreundschuh Peter P. | MA | O | CFO | S | -95 | 6.99 | 0 | -14 | -8 | 149 | D | | | | | | | | | | | | | | |
2/23/22 16:38 | 2/18/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | S.m | -11 | 3.69 | 0 | -3 | -25 | 9 | D | | | | | | | | | | | | | | |
2/18/22 16:14 | 2/16/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | S.dm | -11 | 4.31 | 0 | -3 | -18 | 12 | D | | | | | | | | | | | | | | |
2/16/22 16:59 | 2/15/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | S.d | -6 | 4.33 | 0 | -1 | -9 | 14 | D | | | | | | | | | | | | | | |
10/16/20 15:41 | 10/15/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NJ | O | CFO | S.d | -52 | 21.77 | 0 | -2 | -19 | 10 | D | | | | | | | | | | | | | | |
9/1/20 14:37 | 9/1/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NJ | O | CFO | S.d | -12 | 22.82 | 0 | -1 | -6 | 8 | D | | | | | | | | | | | | | | |
7/28/20 17:34 | 7/27/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NJ | O | CFO | S.d | -3 | 23.51 | 0 | 0 | -2 | 7 | D | | | | | | | | | | | | | | |
5/20/20 16:44 | 5/20/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NJ | O | CFO | S.d | -9 | 25.07 | 0 | 0 | -5 | 7 | D | | | | | | | | | | | | | | |
4/28/20 13:51 | 4/27/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NJ | O | CFO | S.d | -3 | 24.35 | 0 | 0 | -2 | 6 | D | | | | | | | | | | | | | | |
2/24/20 16:53 | 2/20/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NJ | O | CFO | S.d | -11 | 29.68 | 0 | 0 | -6 | 6 | D | | | | | | | | | | | | | | |
1/28/20 17:15 | 1/27/20 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NY | O | CFO | S.d | -20 | 29.28 | 0 | -1 | -13 | 4 | D | | | | | | | | | | | | | | |
11/22/19 13:29 | 11/20/19 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NY | O | CFO | S.d | -10 | 28.41 | 0 | 0 | -9 | 3 | D | | | | | | | | | | | | | | |
8/22/19 13:31 | 8/20/19 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | NY | O | CFO | S.d | -47 | 33.07 | 0 | -1 | -34 | 3 | D | | | | | | | | | | | | | | |